We evaluated the
neuroprotective effects of
atorvastatin (2, 5, and 10 mg/kg) on experimentally induced
intracerebral hemorrhage (ICH) in adult rats; controls were administered PBS. Plasma TNF-α and
IL-10 levels before and after ICH were analyzed at various time points by
enzyme-linked
immunosorbent assay (ELISA) and neurological behavior of rats was assessed by climbing scores. At 3-days postoperatively, brain water contents and TNF-α/IL-10 expression in brain tissue were determined. Histopathological changes and microglial cells in the brain tissue were evaluated by light-microscopy. Post-ICH neurological deficits differed significantly between
sham-operated group A and experimental-ICH group B (P < 0.05). Brain water contents were significantly less in group A than in group B (P < 0.05). Significant differences (P < 0.05) between two groups were observed regarding activated microglia, TNF-α and
IL-10 levels. Compared with group B, neurological deficits, brain water contents, pathological changes, and activated microglia were reduced (P < 0.05) in groups C (Experimental-ICH +
atorvastatin 2 mg/kg), D (Experimental-ICH +
atorvastatin 5 mg/kg) and E (Experimental-ICH +
atorvastatin 10 mg/kg).
Atorvastatin-induced a dose-dependent reduction of TNF-α and increase of
IL-10 levels (P < 0.05). Therefore, it was concluded that
atorvastatin improved neurofunctional rehabilitation in rats through the suppression of
cytokines-mediated inflammatory response and attenuation of brain damage following
intracerebral hemorrhage.